Joachim R Kalden

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

Kerstin Amann, Silke Meister, T. Winkler, 2008, Nature Medicine.

Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.

John Han, Daniel Baker, Paul Emery, 2006, Arthritis and rheumatism.

Advances in rheumatology: new targeted therapeutics

P. Tak, J. Kalden, Paul P Tak, 2011, Arthritis research & therapy.